Results 261 to 270 of about 72,862 (382)

Treatment of refractory hyperlipidemia.

, 1989
Yasushi Saitō, Masaki Shinomiya, Kohji Shirai, Sho Yoshida   +3 more
openalex   +2 more sources

Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Trials of the Glucagon‐like Peptide‐1 Receptor Agonists (GLP1RAs) found mean weight losses of 15%–21%, yet realworld dose titration and persistence remain suboptimal, limiting effectiveness. This study aims to determine real‐world titration, persistence and effectiveness of GLP1RAs in patients managed within a multidisciplinary obesity ...
Jason M. Samuels, Fei Ye, Rebecca Irlmeier, Heidi Silver, Gitanjali Srivastava, Matthew Spann   +5 more
wiley   +1 more source

Nonalcoholic Fatty Liver Disease Risk and Proprotein Convertase Subtilisin Kexin 9 in Familial Hypercholesterolemia Under Statin Treatment. [PDF]

Nutrients
Hamasaki M, Sakane N, Kotani K.
europepmc   +1 more source

[Pathogenesis of hyperlipidemia and fatty liver of rabbits induced by methyl iodide. Increased synthesis and secretion of triglyceride in the liver].

, 1982
Hisao Matsui, Osamu WADA, Shigeo Manabe, Tetsu ONO, Shinichi Komatsu   +4 more
openalex   +2 more sources

Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma [PDF]

, 1991
Groener, J.E.M. (Johanna), Ramshorst, E. (E.) van, Speijer, H. (H.), Tol, A. (Arie) van   +3 more
core   +1 more source

Recent advances in multimodality imaging‐guided therapy in pericarditis

European Journal of Clinical Investigation, EarlyView.
Multiple imaging targets have been identified as essential biomarkers to confirm pericardial thickening, edema, neovascularization, inflammation, fibrosis/calcification, cardiac tamponade physiology, and constriction. This novel approach is called imaging‐guided therapy, which guides anti‐inflammatory therapy, assesses treatment response, assists in ...
Joseph El Roumi, Aldo L. Schenone, Paul Cremer, Tom Kai Ming Wang, Allan Klein   +4 more
wiley   +1 more source

Pharmacogenomics-based systematic review of coronary artery disease based on personalized medicine procedure. [PDF]

Heliyon
Kazemi Asl S, Rahimzadegan M, Kazemi Asl A.   +2 more
europepmc   +1 more source

Analysis of Hyperlipidemia in Diabetic Subjects

, 1982
Keisuke Kosugi, Yutaka Harano, Takamitsu Nakano, Hideki Hidaka, Yukio Shigeta   +4 more
openalex   +2 more sources

Association between CMR‐derived hepatic T1‐time, tricuspid regurgitation and survival

European Journal of Clinical Investigation, EarlyView.
We investigated the association between tricuspid regurgitation (TR) severity and hepatic T1‐time in 1029 patients undergoing cardiac MRI and echocardiography. Hepatic T1‐time increased progressively with TR severity and remained independently associated after adjusting for NT‐proBNP and right ventricular function. Both TR and hepatic T1‐time predicted
Katharina Mascherbauer, Christina Kronberger, Manuel Gruber, Carolina Donà, Matthias Koschutnik, Varius Dannenberg, Michael Poledniczek, Laura Lunzer, Christian Nitsche, Franz Duca, Gregor Heitzinger, Kseniya Halavina, Dietrich Beitzke, Christian Loewe, Michael Trauner, Philipp Bartko, Julia Mascherbauer, Christian Hengstenberg, Andreas Kammerlander, Elisabeth Waldmann   +19 more
wiley   +1 more source